July 2010
Dr. Michael Obuchowski, Ph.D., First Empire Asset Management's Managing Director and Chief Investment Officer, recently appeared in the following publications, television and radio appearances. Article and stock topic excerpts are as follows:
July 26, 2010 - Reuters:
Michael Obuchowski, chief investment officer at Genzyme shareholder First Empire Asset Management, said investors would likely be happy with a price in the $75-$80 range, where the company was trading before it was hit by manufacturing problems in late 2008.
"I think a price in that range would be an attractive one for shareholders because there is still risk associated with the company's recovery from its manufacturing problems," he said. "There are not guarantees everything will go smoothly."
"I really think the field is wide open," said Obuchowski.
July 20, 2010 - Fox Business TV:
Dr. Michael Obuchowski appeared on Fox Business TV on July 20, 2010, to discuss Apple and Yahoo! shares. FEAM's clients hold Apple shares.
July 15, 2010 - Fox Business TV:
Dr. Michael Obuchowski appeared on Fox Business TV on July 15, 2011, to discuss Google shares. FEAM's clients hold Google shares.
July 14, 2010 - Bloomberg TV:
Dr. Michael Obuchowski appeared on Bloomberg TV on July 14, 2011, to discuss Glaxo Smith Kline shares.
July 14, 2010 - Bloomberg:
"Obuchowski Says Avandia Recommendation a "Win" for Glaxo"
Michael Obuchowski, Managing Director and Chief Investment Officer at First Empire Asset Management Inc., spoke to Pimm Fox about the recent recommendation that GlaxoSmithKline PLC keep selling its diabetes pill Avandia on Bloomberg Television's "Taking Stock."
You may see the video by visiting the link below:
http://www.bloomberg.com/news/2010-07-14/obuchowksi-says-avandia-recommendation-a-win-for-glaxo-video.html.html
Contact | Privacy Policy
